EUDA Health (NASDAQ:EUDA) Shares Down 0.8% – Time to Sell?

Shares of EUDA Health Holdings Limited (NASDAQ:EUDA) fell 0.8% on Tuesday . The stock traded as low as $1.19 and last traded at $1.19. 47,163 shares changed hands during mid-day trading, a decline of 94% from the average session volume of 828,436 shares. The stock had previously closed at $1.20.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d)” rating on shares of EUDA Health in a research note on Friday, January 9th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

EUDA Health Price Performance

The stock’s 50-day moving average is $2.20 and its 200 day moving average is $2.36. The stock has a market cap of $44.99 million, a price-to-earnings ratio of -9.92 and a beta of -0.15.

Institutional Trading of EUDA Health

An institutional investor recently raised its position in EUDA Health stock. Citadel Advisors LLC increased its holdings in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 44,631 shares of the company’s stock after acquiring an additional 16,321 shares during the period. Citadel Advisors LLC owned approximately 0.12% of EUDA Health worth $78,000 as of its most recent SEC filing. 4.35% of the stock is currently owned by institutional investors.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.